You have read all your free articles, to continue reading subscribe to read the rest of this content.
The company has entered into an exclusive, global license agreement for orthopedic trauma implants with Zimmer Biomet. The agreement includes an upfront license fee of USD 3 million payable at signing, additional contingent payments of USD 2 million, based on U.S. regulatory clearance and royaltiAlready a subscriber Login You have…
AstraZeneca has entered into an agreement with Aspen Global Incorporated, part of the Aspen Group, under which AGI will now acquire the residual rights to the established anaesthetic medicines comprising of Diprivan, EMLA,Xylocaine/Xylocard/Xyloproct, Marcaine, Naropin, Carbocaine and CitanesAlready a subscriber Login You have read all your free articles, to continue reading subscribe to read the rest of…
Alvotech and Alvotech & CCHT Biopharmaceutical, which is the China joint venture company of Alvotech hf. and Changchun High & New Technology Industries (Group) Inc., have partnered with Yangtze River Pharmaceutical Group to form an exclusive strategic partnership for the commercialization ofAlready a subscriber Login You have read all your…
The Swedish health care company has signed a distribution agreement for India and an exclusive agreement in the UK. BioGaia has signed a non-exclusive agreement with Pharma Base SA for the rights to sell BioGaia’s ProTectis Baby Drops in India. Under the agreement, Pharma Base will cooperate wiAlready a subscriber…
